🔗 Share this article

An underground economy for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down problematic content and banned associated hashtags and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing reviews and detailed guides for mixing or administering at home.

Within minutes of entering one community, a seller shared contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Item Information and Pricing

Within these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.